260 related articles for article (PubMed ID: 20921123)
1. Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study.
Umhau JC; Momenan R; Schwandt ML; Singley E; Lifshitz M; Doty L; Adams LJ; Vengeliene V; Spanagel R; Zhang Y; Shen J; George DT; Hommer D; Heilig M
Arch Gen Psychiatry; 2010 Oct; 67(10):1069-77. PubMed ID: 20921123
[TBL] [Abstract][Full Text] [Related]
2. Anterior Cingulate Glutamate Is Reduced by Acamprosate Treatment in Patients With Alcohol Dependence.
Frye MA; Hinton DJ; Karpyak VM; Biernacka JM; Gunderson LJ; Feeder SE; Choi DS; Port JD
J Clin Psychopharmacol; 2016 Dec; 36(6):669-674. PubMed ID: 27755217
[TBL] [Abstract][Full Text] [Related]
3. Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study.
Soyka M; Preuss U; Schuetz C
Drugs R D; 2002; 3(1):1-12. PubMed ID: 11881521
[TBL] [Abstract][Full Text] [Related]
4. Central effects of acamprosate: part 2. Acamprosate modifies the brain in-vivo proton magnetic resonance spectrum in healthy young male volunteers.
Bolo N; Nédélec JF; Muzet M; De Witte P; Dahchour A; Durbin P; Macher JP
Psychiatry Res; 1998 May; 82(2):115-27. PubMed ID: 9754454
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.
Berger L; Fisher M; Brondino M; Bohn M; Gwyther R; Longo L; Beier N; Ford A; Greco J; Garbutt JC
Alcohol Clin Exp Res; 2013 Apr; 37(4):668-74. PubMed ID: 23134193
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. A 90-day placebo-controlled dose-finding study.
Pelc I; Verbanck P; Le Bon O; Gavrilovic M; Lion K; Lehert P
Br J Psychiatry; 1997 Jul; 171():73-7. PubMed ID: 9328500
[TBL] [Abstract][Full Text] [Related]
7. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
[TBL] [Abstract][Full Text] [Related]
8. Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence.
Kampman KM; Pettinati HM; Lynch KG; Xie H; Dackis C; Oslin DW; Sparkman T; Sharkoski T; O'Brien CP
Addict Behav; 2009; 34(6-7):581-6. PubMed ID: 19345510
[TBL] [Abstract][Full Text] [Related]
9. Acamprosate for alcohol dependence: a sex-specific meta-analysis based on individual patient data.
Mason BJ; Lehert P
Alcohol Clin Exp Res; 2012 Mar; 36(3):497-508. PubMed ID: 21895717
[TBL] [Abstract][Full Text] [Related]
10. Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials.
Kranzler HR; Gage A
Am J Addict; 2008; 17(1):70-6. PubMed ID: 18214726
[TBL] [Abstract][Full Text] [Related]
11. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
[TBL] [Abstract][Full Text] [Related]
12. Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study.
Besson J; Aeby F; Kasas A; Lehert P; Potgieter A
Alcohol Clin Exp Res; 1998 May; 22(3):573-9. PubMed ID: 9622434
[TBL] [Abstract][Full Text] [Related]
13. Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence.
Scott LJ; Figgitt DP; Keam SJ; Waugh J
CNS Drugs; 2005; 19(5):445-64. PubMed ID: 15907154
[TBL] [Abstract][Full Text] [Related]
14. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.
Mason BJ; Goodman AM; Chabac S; Lehert P
J Psychiatr Res; 2006 Aug; 40(5):383-93. PubMed ID: 16546214
[TBL] [Abstract][Full Text] [Related]
15. Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain.
Gual A; Lehert P
Alcohol Alcohol; 2001; 36(5):413-8. PubMed ID: 11524307
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamic-pituitary-adrenal system regulation in recently detoxified alcoholics is not altered by one week of treatment with acamprosate.
Zimmerman U; Spring K; Koller G; Holsboer F; Soyka M
Pharmacopsychiatry; 2004 May; 37(3):98-102. PubMed ID: 15179967
[TBL] [Abstract][Full Text] [Related]
17. Acamprosate in the treatment of alcohol dependence.
Mason BJ
Expert Opin Pharmacother; 2005 Oct; 6(12):2103-15. PubMed ID: 16197362
[TBL] [Abstract][Full Text] [Related]
18. Acamprosate: A Review of Its Use in Alcohol Dependence.
Plosker GL
Drugs; 2015 Jul; 75(11):1255-68. PubMed ID: 26084940
[TBL] [Abstract][Full Text] [Related]
19. The clinical pharmacology of acamprosate.
Kalk NJ; Lingford-Hughes AR
Br J Clin Pharmacol; 2014 Feb; 77(2):315-23. PubMed ID: 23278595
[TBL] [Abstract][Full Text] [Related]
20. Acamprosate for the treatment of alcohol dependence.
Boothby LA; Doering PL
Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]